spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mesri, E. A.
Right arrow Articles by Pastan, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mesri, E. A.
Right arrow Articles by Pastan, I.
Austin, G. E., Ratliff, N. B., Hollman, J., Tabeil, S. and Phillips, D (1987). Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery restenosis after coronary angioplasty. J. Amer. Coll. Cardiol 6, 369-375.

Baldin, V., Roman, A. M., Bosc-Bierne, I., Amalric, F. and Bouche, G (1990). Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. EMBO J 9, 1511-1517.[Medline]

Besner, G. A., Whelton, D., Crissman-Combs, M. A., Steffen, C. L., Kim, G. Y. and Brigstock, D. R (1992). Interaction of heparin-binding EGF-like growth factor (HB-EGF) with the epidermal growth factor receptor: modulation by heparin, heparinase or synthetic heparin-binding HB-EGF fragments. Growth Factors 7, 289-296.[Medline]

Burgess, W. H. and Maciag, T (1989). The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem 58, 575-606.[Medline]

Busch, S. J., Martin, G. A., Barnhart, R. L., Mano, M., Cardin, A. D. and Jackson, R. L (1992). Trans repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein mediated transcription. J. Cell Biol 116, 31-42.[Abstract/Free Full Text]

Cascells, W., Lappi, D. A., Olwin, B. B., Wai, C., Siegman, M., Speir, E. H., Sasse, J. and Baird, A (1992). Elimination of smooth muscle cells inexperimental restenosis: Targeting of fibroblast growth factor receptors. Proc. Nat. Acad. Sci. USA 89, 7159-7163.[Abstract/Free Full Text]

Chaudhary, V. K., Jinno, Y., FitzGerald, D. and Pastan, I (1990). Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity. Proc. Nat. Acad. Sci. USA 87, 308-312.[Abstract/Free Full Text]

Chaudhary, V. K., Jinno, Y., Gallo, M. G., FitzGerald, D. and Pastan, I (1990). Mutagenesis of Pseudomonas exotoxin in identification of sequences responsible for the animal toxicity. J. Biol. Chem 265, 16306-16310.[Abstract/Free Full Text]

Dingwall, C. and Laskey, R. A (1991). Nuclear targeting sequences- a consensus. Trends Biochem. Sci 16, 478-481.[Medline]

Dluz, S. M., Higashiyama, S., Damm, D., Abraham, J. and Klagsbrun, M (1993). Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen. J. Biol. Chem 268, 18330-18334.[Abstract/Free Full Text]

Epstein, S. E., Siegall, C. B., Biro, S., Fu, Y., FitzGerald, D. and Pastan, I (1991). Cytotoxic effects of a recombinant chimeric toxin on rapidly proliferating vascular smooth muscle cells. Circulation 84, 778-787.[Abstract/Free Full Text]

Esko, J. D., Rostand, K. S. and Weinke, J. L (1988). Tumor formation dependent on proteoglycan biosynthesis. Science 241, 1092-1096.[Abstract/Free Full Text]

FitzGerald, D. J. P., Morris, R. E. and Saelinger, C. B (1980). Receptor-mediated internalization of Pseudomonas toxin by mouse fibroblasts. Cell 21, 867-873.[Medline]

Fu, Y.-M., Mesri, E. A., Yu, Z.-Y., Pastan, I. and Epstein, S. E (1993). Cytotoxic effects on vascular smooth muscle cells of the chimeric toxin heparin-binding transforming growth factor alpha- Pseudomonas exotoxin. Cardiovasc. Res 27, 1691-1697.[Medline]

Gannoun-Zaki, L., Pierri,, I., Badet, J., Moenner, M. and Barritault, D (1991). Internalization of basic fibroblast growth factor by Chinese hamster lung fibroblast cells: Involvement of several pathways. Exp. Cell. Res 197, 272-279.[Medline]

Hanneken, A., de Juan, E. J., Lutty, G., Fox, G., Schiffer, S. and Hjemmeland, L (1991). Altered distribution of basic fibroblast growth factor in diabetic retinopathy. Arch. Ophtalmol 109, 1005-1011.

Higashiyama, S., Abraham, J., Miller, J., Fiddes, J. and Klagsbrun, M (1991). A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251, 936-938.[Abstract/Free Full Text]

Higashiyama, S., Lau, K., Besner, G. E., Abraham, J. A. and Klagsbrun, M (1992). Structure of heparin-binding EGF like growth factor. J. Biol. Chem 267, 6205-6212.[Abstract/Free Full Text]

Higashiyama, S., Abraham, J. and Klagsbrun, M (1993). Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: Dependence on interaction with cell surface heparan sulfate. J. Cell. Biol 122, 933-940.[Abstract/Free Full Text]

Hwang, J., FitzGerald, D. J., Adhya, S. and Pastan, I (1987). Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell 48, 129-136.[Medline]

Imamura, T., Engleka, K., Zhan, X., Tokita, Y., Forough, R., Roeder, D., Jackson, A. J., Maier, J. A. M., Hla, T. and Maciag, T (1990). Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science 249, 1567-1570.[Abstract/Free Full Text]

Johnson, G. R., Saeki, T., Auersperg, N., Gordon, A. W., Shoyab, M., Salomon, D. S. and Stromberg, K (1991). Response to and expression of amphiregulin by ovarian carcinoma and normal ovarian surface epithelial cells: Nuclear localization of endogenous amphiregulin. Biochem. Biophys. Res. Commun 180, 481-488.[Medline]

Karnovsky, M. J., Wright, T. C. J., Castellot, J. J. J., Choay, J., Lormeau, J.-C. and Petitou, M (1989). Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis. Ann. NY Acad. Sci 556, 268-281.[Medline]

Kjellen, L. and Lindahl, U (1991). Proteoglycans: Structures and interactions. Annu. Rev. Biochem 80, 443-475.

Klagsbrun, M. and Baird, A (1991). A dual receptor system is required for basic fibroblast growth factor activity. Cell 67, 229-231.[Medline]

Kreitman, R. J., Chaudhary, V. K., Siegall, C., FitzGerald, D. J. and Pastan, I (1991). Rational design of a chimeric toxin: An intramolecular location for the insertion of transforming growth factor alpha within Pseudomonas exotoxin as a targeting ligand. Bioconjug. Chem 3, 58-62.

Laemmli, U. K (1970). Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227, 680-685.[Medline]

Linhardt, R. J., Turnbull, J. E., Wang, H. M., Loganathan, D. and Gallagher, J. T (1990). Examination of the substrate specificity of heparin and heparan sulphate lyases. Biochemistry 29, 2611-2617.[Medline]

Lorberboum-Galski, H., Garsia, R. J., Gately, M., Brown, P. S., Clark, R. E., Waldmann, T. A., Chaudhary, V. K., FitzGerald, D. J. and Pastan, I (1990). IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes. J. Biol. Chem 265, 16311-7.[Abstract/Free Full Text]

Makino, H., Ikeda, S., Haramoto, T. and Ota, Z (1992). Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy. Nephron 61, 415-421.[Medline]

Mesri, E. A., Kreitman, R. J., Fu, Y.-M., Epstein, S. E. and Pastan, I (1993). Heparin binding transforming growth factor alpha- Pseudomonas exotoxin A: A heparan sulfate proteoglycan modulated chimeric toxin cytotoxic to cancer and proliferating smooth muscle cells. J. Biol. Chem 268, 4853-4862.[Abstract/Free Full Text]

Modrell, B., McDonald, V. and Shoyab, M (1992). The interaction of amphiregulin with nuclei and putative nuclear localization sequence binding protein. Growth Factors 7, 305-314.[Medline]

Nakanishi, Y., Kihara, K., Mizuno, K., Masamune, Y., Yoshitake, Y. and Nishikawa, K (1992). Direct effect of basic fibroblast growth factor on gene transcription in a cell free system. Proc. Nat. Acad. Sci USA 89, 5216-5220.[Abstract/Free Full Text]

Pastan, I., Willingham, M. C. and FitzGerald, D. J. P (1986). Immunotoxins. Cell 47, 641-648.[Medline]

Pastan, I. and FitzGerald, D (1989). Pseudomonas exotoxin: chimeric toxins. J. Biol. Chem 264, 15157-15160.[Abstract/Free Full Text]

Pastan, I., Chaudhary, V. K. and FitzGerald, D. P (1992). Recombinant toxins, novel therapeutic agents. Annu. Rev. Biochem 61, 331-354.[Medline]

Pickering, J. G., Bacha, P. A., Weir, L., Jakanowski, J., Nichols, J. C. and Isner, J. M (1993). Prevention of smooth muscle cell outgrowth from human atherosclerotic plaque by a recombinant cytotoxin specific for the epidermal growth factor receptor. J. Clin. Invest 91, 724-729.

Rapraeger, A. C., Krufka, A. and Olwin, B. B (1991). Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252, 1705-1708.[Abstract/Free Full Text]

Reiland, J. and Rapraeger, A. C (1993). Heparin sulfate proteoglycan and FGF target basic FGF to different intracellular destinations. J. Cell Sci 105, 1085-1093.[Abstract]

Roghani, M. and Moscatelli, D (1992). Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate proteoglycan-mediated mechanisms. J. Biol. Chem 267, 22156-22162.[Abstract/Free Full Text]

Ross, R (1993). The pathogenesis of atherosclerosis: a perspective for the 90's. Nature 362, 801-809.[Medline]

Ruoslahti, E. and Yamaguchi, Y (1991). Proteoglycans as modulators of growth factor activities. Cell 64, 867-869.[Medline]

Rusnati, M., Urbinati, C. and Presta, M (1993). Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: Role of the low affinity heparin-like bFGF receptors. J. Cell. Physiol 154, 154-162.

Seetharam, S., Chaudhary, V. K., FitzGerald, D. and Pastan, I (1991). Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL. J. Biol. Chem 266, 17376-17381.[Abstract/Free Full Text]

Shoyab, M., Plowman, G., McDonald, V., Bradley, J. G. and Todaro, G. J (1989). Structure and function of human amphiregulin: A member of the epidermal growth factor family. Science 243, 1074-1076.[Abstract/Free Full Text]

Siegall, C. B., Epstein, S., Speir, E., Hla, T., Forough, R., Maciag, T., FitzGerald, D. J. and Pastan, I (1991). Cytotoxic activity of chimeric proteins composed of acidic fibroblast growth factor and Pseudomonas exotoxin on a variety of cell types. FASEB J 5, 2843-2849.[Abstract]

Temizer, D. H., Yoshizumi, M., Perrella, M., Sussani, E., Quertermous, T. and Lee, M.-E (1992). Induction of heparin-binding epidermal growth factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells. J. Biol. Chem 267, 24892-24896.[Abstract/Free Full Text]

Thompson, S. A., Higashiyama, S., Wood, K., Pollit, N. S., Damm, D., McEnroe, G., Garrick, B., Ashton, N., Lau, K., Hancock, N., Klagsbrun, M. and Abraham, J. A (1994). Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin. J. Biol. Chem 269, 2541-2549.[Abstract/Free Full Text]

Vitetta, E. S., Fulton, R. J., May, R. D., Till, M. and Uhr, J. W (1987). Redesigning nature's poisons to create anti-tumor reagents. Science 238, 1098-1104.[Abstract/Free Full Text]

Wight, T. N., Kinsella, M. G. and Qwarnstrom, E. E (1992). The role of proteoglycans in cell adhesion, migration and proliferation. Curr. Opin. Cell Biol 4, 793-801.[Medline]

Woolf, N (1990). Pathology of atherosclerosis. Br. Med. Bull 46, 960-985.[Abstract/Free Full Text]

Yanagishita, M. and Hascall, V. C (1992). Cell surface heparan sulphate proteoglycans. J. Biol. Chem 267, 9451-9454.[Free Full Text]

Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P. and Ornitz, D. M (1991). Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848.[Medline]


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
C. Ebihara, M. Kondoh, N. Hasuike, M. Harada, H. Mizuguchi, Y. Horiguchi, M. Fujii, and Y. Watanabe
Preparation of a Claudin-Targeting Molecule Using a C-Terminal Fragment of Clostridium perfringens Enterotoxin
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 255 - 260.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
B. Paria, K Elenius, M Klagsbrun, and S. Dey
Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation
Development, January 5, 1999; 126(9): 1997 - 2005.
[Abstract] [PDF]

This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mesri, E. A.
Right arrow Articles by Pastan, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mesri, E. A.
Right arrow Articles by Pastan, I.